Verrica Pharmaceuticals Inc.
Nasdaq VRCA · West Chester, PA
Works in Dermatology · Infectious disease · Renal & urogenital
Verrica Pharmaceuticals Inc. is a clinical trial sponsor based in West Chester, PA, listed as Nasdaq VRCA. It has 4 active clinical trials with 882 planned participants, in Dermatology, Infectious disease and Renal & urogenital. Since 2021 it has completed 6 trials and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq VRCA
Fundraising
Pipeline · 4 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
1 approved drug application with a product on the market.
Questions about Verrica Pharmaceuticals Inc
Verrica Pharmaceuticals Inc is lead sponsor of 4 active clinical trials on ClinicalTrials.gov, with 882 planned participants, in Dermatology, Infectious disease, Renal & urogenital. Since 2021 it has completed 6 trials and stopped 0 early.
Verrica Pharmaceuticals Inc is based in West Chester, PA and is listed as Nasdaq VRCA. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Verrica Pharmaceuticals Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-23.
Approve Suite is not affiliated with Verrica Pharmaceuticals Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.